Cancer Treatment Centers of America is a network made of five hospitals. The headquarters are in Boca Raton, Florida. They treat cancer patients who spread all over the United States. The hospitals adopt an approach that is integrated into treatment of cancer. This approach makes use of conventional methods which include chemotherapy, surgery, immunotherapy, and radiation for the treatment of cancer. In addition, they offer therapies that are integrative so as to overcome the side effects of this treatment.
The inspiration behind the founding of these centers came after the death of the founder’s mother died of cancer. Stephenson J. Richard’s is the founder. Dissatisfied with options for treatment available for his mother then, Stephenson opened the first Cancer Treatment Centers of America hospital. The hospital was opened in the year 1988. Others were opened from 2005 to 2012. The hospitals are accredited. They have earned awards for quality and gained recognition for patient satisfaction.
In their endeavor to get the right treatment for cancer and give their patients the best, the Cancer Treatment Centers of America has partnered with AllScripts and NantHealth. The collaboration is aimed at executing a technical solution that is custom. This solution will enable eviti, a product of NantHealth, gain entry to clinical workflows of Sunrise electronic health record at the Allscripts. The program, referred to as Pathways program will allow the process of cancer treatment without interrupting the workflow of the physician.
The work of coming up with the clinical operating system known as NantOs involved oncologists numbering hundreds spread all over the nation. The program holds a collection of data for cancer care which is comprehensive and evolving. The program is set mindful of the patient and integrates research for cancer that is latest, treatment and therapies that are complementary.
The program will offer transparency in the delivery of care and selection of therapy. In addition, efficiency and quality will be improved. The confidence of the patients will be improved since the program will offer a discussion between the clinical team and the patient on the appropriate treatment given their diagnosis.
Cancer is now considered as one of the biggest killer diseases in the 21st century. Although a lot of efforts have been put to wipe the menace out of the earth’s surface, there is a lot that still needs to be done. One of the biggest strides made by researchers and physicians in the treatment of cancer is availing the most critical information needed during the cancer treatment. One of the organizations that are working tirelessly to ensure that cancer patients get better treatment options is the cancer treatment centers of America. Cancer centers of America work very hard to ensure that they provide the best treatment options for different types of cancer. The Cancer Centers Treatment of America is an affiliation of five nationally recognized hospitals that focus on providing the best services to cancer patients.
The Cancer Centers Treatment of America invests substantial amount resources in research and also engages in meaningful partnerships that benefit individuals with various types of cancer either directly or indirectly. In the most recent move, Cancer Centers Treatment of America teamed up with Allscripts and Nanthealth to make cancer treatment as seamless as possible.
The new arrangement with the three reputable organizations will help oncologists and physicians from every corner of the country to work together with their patients throughout the treatment process. In the last few years, a number of discoveries in cancer treatment have grown exponentially. At least, there seems to be light at the end of the tunnel. However, despite the remarkable strides made by oncologists, they have been faced with the challenge of sharing critical information with other oncologists. The new partnership seeks to address this problem by providing the much-needed information to both patients and physicians.
The new program launched by the three organizations is known as Clinical Pathways. Nanthealth have also incorporated their support solution known as eviti into the clinical pathways program. The eviti program was designed with the input of oncologists from all over the country.
Dr. Mikhail Blagosklonny is renowned for his advocacy for Rapamycin. Rapamycin, which is also known as Sirolimus, was first discovered in samples of Easter Island bacterium in 1972. Initially, scientists used Sirolimus as an antifungal agent but later discovered its immunosuppressive and antiproliferative nature. With these properties, Rapamycin, which was commercialized as Rapamune, has continued to be used widely. Firstly, the drug’s immunosuppressive properties allow it to be used during organ transplantation to reduce the rate of rejection by displaying a lower level of toxicity to the kidneys. It is also used to treat hemolytic-uremic syndrome, which includes kidney failure. Its effect of lowering toxicity levels helps in reducing the rate of infection to the new transplanted kidney. Rapamycin is used to treat Lymphangioleiomyomatosis (LAM), a condition that infiltrates the tissues in the lungs with mutations of the TSC2- Tuberous Sclerosis Complex, hence activating the MTOR signaling gateway. Rapamycin works by blocking the gateway.
Rapamycin plays an important role during balloon angioplasty procedure given that it is used to coat the coronary stents to block the occurrence of re-stenosis in the arteries. There is no need to repeat the procedure when Sirolimus coating is used. Its anti-proliferative properties enhance the body’s immunity towards tumors for cancer patients. It also reduces the chances of contracting cancer in case of organ transplant. In TSC-Tuberculosis Sclerosis Complex treatment, Rapamycin, which is an MTOR inhibitor, suppresses TSC. Since most TSC patients suffer from facial angiofibromas, Rapamycin can be used in the form of gel, cream or ointments to treat the disease. Mikhail’s research revealed that Sirolimus extends life in mice. This is a big step towards applying it in human longevity. Other studies are being carried out to determine Rapamycin’s use in treating Alzheimer, muscular dystrophy and Systematic Lupus Erythematosus (SLE). This information was originally mentioned on Philly Purge as outlined in this.
Dr. Mikhail Blagosklonny works for the Rosewell Park Cancer Institute as a professor of oncology. Over the years, he has extensively researched and published numerous works on cancer and aging. Notably, Mikhail studies have shown a connection between cancer and aging considering that cancer is more likely to occur as an individual ages. His pursuit of finding cure for cancer is inspired by his desire to help patients around the world. At Rosewell Park, Mikhail has played a pivotal role of leading his peers and motivating students to expand their research on cancer and aging.Unlike other scientists, Mikhail not only researches on the innovative methods of treating cancer, but also looks for effective and affordable ways that will not harm patients by destroying the normal cells. The renowned scientist believes that everyone is entitled to proper cancer treatment, unlike the current situation where effective therapies are a luxury afforded only by the rich. Mikhail strives to make exceptional contributions in the cancer research for purposes of helping people access cost effective treatments. His keen attention to detail has distinguished him from other scientists in the field. His work has continued to be published by impact journals. Mikhail Blagosklonny hopes that his work will inspire other professionals to enhance their research on various therapies.
James Dondero is Highland Capital Management’s chief executive officer. He studied his Accounting and Finance degree at the University of Virginia which he has used to thrive in the business world. Besides business and finances, James is also a renowned philanthropist who has partnered with various charitable organizations who are committed to giving back to the community. Dallas Foundation is one of his partners, they have managed to budget economically for their charitable projects both locally and internationally.
James Dondero sees philanthropy as one of his major goals in life, and he has worked tirelessly with many other organizations with the same passions to ensure that the needs of the less fortunate are met. Agencies such as Dallas Foundation have been of great help to the company for it has helped it connect and establish strong relationships with these needy people.
James Dondero as the head of the company has set some goals for the company and charity is one the major one. The company, therefore, ensures that every employee works to their level best hence earning the company great profits of which some gets channeled into generous giving. James has had education and healthcare be the driving force behind his philanthropic work because he believes that a healthy and educated society has a secure future because the needs of its next generation are met actively. Charity and business go hand in hand. It works on the policy that the more you give, the more you receive, and indeed James’ company has seen the light of this.
James has achieved great success and enormous blessings due to his generosity. He has employed ways of ensuring sure that his company doesn’t sink in its operations despite his involvement in philanthropic work. He has therefore managed to oversee the company’s operations as its CEO and has been able to maintain the amounts of profits it earns at the end of every financial year. For some time now, the company has increased its earnings hence upholding its success.
All in all, a hand that gives receives even more, and Highland Capital Management under the leadership of James Dondero is living proof.
The best treatment for the prevention of cancer is early detection. In September, The National Football League (NFL) joined with Cancer Treatment Centers of America and LabCorp to educate men concerning the risks of prostate cancer and to offer specialized Prostate Specific Antigen(PSA)screening.
The American Cancer Society estimates that 1 in 7 men will be diagnosed with the disease in their lifetime. Early intervention is key to a successful treatment plan. The goal is to educate men about their risks and encourage them to get a screening. Age and race are factors with African American men having an increased risk factor.
Cancer Treatment Centers of America has locations in 5 major cities throughout the United States. Each has a state-of-the-art cancer center staffed by experts trained in the latest technologies, techniques, and therapy services to provide total patient care.
What Makes Their Approach to Treating Cancer Different?
CTCA’s cancer experts promote precision cancer treatment, that is attacking cancer at the cellular level using the latest technologies. They have a variety of diagnostic tools to analyze and target cancer cells to understand what makes them grow, through this kind of research, treatments are more effective and have the least side effects.
Each patient is an individual and their care is designed for their individual needs. A team of physicians and therapists work with patients to fight cancer through medicine, anti-cancer drugs, and immune system support to help the patient stay healthy and energized during and after treatment. CTCA’s Integrative Care program uses a combination of conventional treatments with supportive therapy to deliver the best in patient-centered care.
According to an article published on the PRNewswire.com, prostate cancer is one of the many deadliest cancer diseases which affect the men’s productive system, in the United States of America. Research shows that in a group of about seven men there exists one man who is suffering from the prostate cancer.
To fight with this increasing number of men suffering from this disease, groups like National Football League Alumni Association, Cancer Treatment Centers of America and LabCorp organization have come together to increase the awareness and to advise men for the screening to know their health and educate men on the need for screening.
The men of around 40 years are advised to sign up with LabCorp to receive a free prostate cancer screening. The processes are aimed at helping more men and reducing the disease. Hence the organization is urging men to take this opportunity and know their health status.
About the CTCA (Cancer Treatment Centers of America)
It’s an organization formed by a group of hospitals. The organization was formed as a nonprofit group that deals with cancer patients in the United States. The services the CTCA offers to patients include surgery, chemotherapy, radiation, as well as immunotherapy to combat cancer disease; other services include therapies which help the cancer patients to manage cancer side effects like the pain.
The hospitals that formed the Cancer Treatment Center of America which are:
• Southeastern Regional Medical Center, which is based in the Atlanta Georgia
• Midwestern Regional Medical Center, based in Chicago Illinois
• Eastern Regional Medical Center, which is situated in the Philadelphia Pennsylvania
• Western Regional Medical Center, located in the Phoenix Arizona
• Southwestern Regional Medical Center, which is based in the Tulsa Oklahoma
All these hospitals have joined together and offered themselves to bring the cancer services to the ground.
Rodrigo Terpin’s boldness, tact, passion, and dedication gets most of his peers and colleagues in the rally fraternity by surprise. How he manages to stay committed and satisfied at the same requires a great deal of discipline: a virtue that he has cultivated since he started car rallying, two decades ago. In observing these qualities and values, Rodrigo is a leader on and off-track due to his ability to drive his ‘community’ of rally drivers towards a common of the objective.
His Dedication and Zeal
In the competitive and crowded rallying sport in Brazil, finding personalities such as Rodrigo, who despite their experience and age remain discipline and dedicate to this game becomes challenging. He has won numerous awards both in and out of Brazilian soil, and through this, he has remained a force to reckon with as far as Brazilian motorsport championship is concerned. One outstanding rally event that he participates in refers to the Rally dos Sertoes which is an annual event held in over ten towns in Eastern Brazil. It is through the Sertoes Rally event that he even horned his rallying skills and hence his consistent participation in the annual event as a gesture towards nurturing other drivers.
His Achievements as a Rally Driver
Regarding his participation in the previous Sertoes rallies, Rodrigo is credited with bagging 7 top finishes and several other top 5 finishes. Such incredible performances make him the most decorated rally driver in the event since its inception in 1992. As a member of the Bull Sertoes team, he also inspired his brother to quit motor racing for the sake of the T1 car category. As inexperienced as Michel was, he was patient with him and nurtured him to perfection as a professional rally driver. Check out Terra to know more.
Apart from his life as a professional life as a rally driver, Rodrigo Terpin is also a renowned spiritual writer who has amassed over ten years of experience in editorial work. His editorial work is mostly centered in major Brazilian magazines and journals. Terpins is also a businessman with interests in the entertainment and real estate sector.
The success of Sweetgreen has seen the company emerge as a pacesetter in the restaurant business. The company’s immense success in the food industry is attributable to their use of healthy, organic, fresh and local ingredients in the preparation of their delicious salads.
The resonation of the recipe with diners has further increased their clientele at all Sweetgreeen’s 40 locations.
Nathaniel Ru the company’s CEO posits that their primary focus is to create a brand that not only stands for something but also serves better, healthier food to more people. A pacesetter in the food industry, Sweetgreen has gone an extra mile to streamline their operations through the incorporation of technology.
That has been greatly facilitated by the fact that the company’s co-CEOs have been tech pioneers. Speaking regarding the use of technology in their business, Ru holds that technology has always been at the core of their business.
Ru and his co-CEOs are also reshaping their management strategies. For instance, Sweetgreen shuts down all its corporate offices, each year a total of five times to ensure that all of their employees get to work in its restaurants.
The overall aim of this strategy is to ensure that their workforce stays close to their clients, hence obtaining a better understanding of customer needs.
The decentralization of the company’s headquarters is also part of the change in management strategy. Read more: Nathaniel Ru | Crunchbase
To date, Sweetgreen operates without centralized headquarters despite the exponential growth that has seen the company recently open offices in Los Angeles.
The trio of Ru and his fellow co-CEOs Neman and Jammet were classmates at the Georgetown University. Coincidentally, their parents are immigrant business owners, making them first-generation immigrants.
Their business venture is said to have been born out of the realization that Georgetown didn’t have enough healthy eating options.
Dr. Cameron Clokie performed a procedure on him that stimulated his stem cells into becoming a bone tissue to fill the lost part of his jaw. Unlike traditional methods that are often painful and difficult to perform, regenerative medicine as practiced at Toronto General Hospital and Mount Sinai Hospital is less painful and relatively easier to implement.
Although Russel still needs a little support to move his jaw, pundits agree that the procedure carried out on him is promising.
Presently, Dr. Cameron Clokie is the CEO of Induce Biologics Inc. The organization is focused on using regenerative medicine to offer new ways of musculoskeletal reconstruction.
According to Bloomberg, Dr. Clokie’s experience spanning over three decades in academic dentistry and clinical practice has given him an upper hand in matters regenerative medicine. His work in the academic and clinical fields culminated in his appointment as the Head of Oral and Maxillofacial Surgery in 1998 in the University of Toronto.
Before Dr. Clokie retired (in 2017), he was the Professor of Oral and Maxillofacial Surgery at the same university. Dr. Clokie is an accomplished academician who has published numerous papers and done many presentations both in Canada and abroad on his dear subject: regenerative medicine.
Mikhail Blagosklonny is among the world leading scientists in the aging and cancer. He is a top oncology professor and has conducted significant research in the field. Blagosklonny currently works at the Roswell Park Cancer Institute. The scientist is an alumnus of the First Pavlov State Medical University of St. Petersburg where he got his Ph.D. in experimental medicine and cardiology and a master’s degree in internal medicine. In 2002, Mikhail was appointed as an associate professor at the New York Medical College. He served the organization for a few years before being hired as a senior scientist at the Ordway Research Institute. In 2009, the professor joined the Roswell Park Cancer Institute, and he has been serving it to date. Blagosklonny has gained a wealth of experience in oncology for the years that he been in the field, and this enables him to be highly useful at the institute. He has currently focused researching areas such as cancer, biogerontology, anti-aging, and various targeted cancer therapies that do not have an adverse effect in healthy cells.
The scientist works at Oncotarget and Cell Cycle as an editor in chief. He has also been acting as an associate editor in therapy and cancer biology. Mikhail has had an opportunity to be part of the researchers who serve on the Cell Death and Differentiation’s editorial board. The professor has developed a hypothesis that focuses on how medical professionals can utilize TOR signaling potential in the treatment of aging and cancer problems. He encourages the use Rapamycin, which is a strong cure for cancer. Mikhail has actively taken part in longevity research. The fields that the professor has dealt with include clinical investigations, molecular biology, and cellular biology. In his career, he has studied about tumor suppressors, drug resistance, ontogenesis, anticancer therapeutics, apoptosis, mitosis, and signal transduction.
Mikhail Blagosklonny has written a lot of the useful content that enlightens people about the aging hyperfunction theory. He has discussed cyclotherapy engineering and cell chemotherapeutic. The professor is globally appreciated due to the research that he has done. He believes that Rapamycin can be used in treating individuals who have cancer. Blagosklonny has currently written more than 300 book chapters, research articles, and reviews. His knowledge has made the International Journal of Cancer, American Journal of Pathology, PLoS ONE, and many other organizations to hire him as an associate editor. He is a hardworking and committed person, and this has enabled him to be among the most successful oncology researchers. Mikhail believes that he values human life, and this inspired him to join the sector so that he could make the world disease free.The useful research work that Blagosklonny does has significantly benefited the Roswell Park Cancer Institute since he joined it in 2009. The organization has been acting as a place where different professionals can come together and share their approaches in how cancer can be cured. Roswell Park Cancer Institute’s scientists are currently working to determine how aging can be prevented by curing cancer. Mikhail’s oncology expertise has been useful to the institute.